MedPath

ess invasive surfactant administration (LISA) in preterm infants in level III, neonatal intensive care units in Germany.- An online-survey on the implementation of surfactant administration in preterm infants.

Conditions
eonatal Respiratory Distress Syndrom
P22
Respiratory distress of newborn
Registration Number
DRKS00031000
Lead Sponsor
Abteilung für Neonatologie, Universitätskinderklinik Tübingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
122
Inclusion Criteria

Physicians in NICUs (maximum care, Level III)

Exclusion Criteria

Physicians of the same department

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presentation of relevant technical details of the current LISA implementation and the general acceptance of LISA in Germany.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath